Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems

An investigation of the formation of fused- and spiro-β-lactone annulate to γ-lactams has shown that the fused systems are formed preferentially, under standard conditions, but that spiro systems are accessible only when the formation of the fused system is blocked and require careful optimisation o...

Full description

Bibliographic Details
Main Authors: Josa-Culleré, L, Towers, C, Willenbrock, F, Macaulay, V, Christensen, K, Moloney, M
Format: Journal article
Language:English
Published: Royal Society of Chemistry 2017
_version_ 1826258837540175872
author Josa-Culleré, L
Towers, C
Willenbrock, F
Macaulay, V
Christensen, K
Moloney, M
author_facet Josa-Culleré, L
Towers, C
Willenbrock, F
Macaulay, V
Christensen, K
Moloney, M
author_sort Josa-Culleré, L
collection OXFORD
description An investigation of the formation of fused- and spiro-β-lactone annulate to γ-lactams has shown that the fused systems are formed preferentially, under standard conditions, but that spiro systems are accessible only when the formation of the fused system is blocked and require careful optimisation of reaction conditions. These systems display both weak antibacterial activity and proteasome inhibition.
first_indexed 2024-03-06T18:40:18Z
format Journal article
id oxford-uuid:0ca53d31-83ad-44fa-97f6-f1114995a61b
institution University of Oxford
language English
last_indexed 2024-03-06T18:40:18Z
publishDate 2017
publisher Royal Society of Chemistry
record_format dspace
spelling oxford-uuid:0ca53d31-83ad-44fa-97f6-f1114995a61b2022-03-26T09:36:09ZSynthesis and bioactivity of fused- and spiro-β-lactone-lactam systemsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0ca53d31-83ad-44fa-97f6-f1114995a61bEnglishSymplectic Elements at OxfordRoyal Society of Chemistry2017Josa-Culleré, LTowers, CWillenbrock, FMacaulay, VChristensen, KMoloney, MAn investigation of the formation of fused- and spiro-β-lactone annulate to γ-lactams has shown that the fused systems are formed preferentially, under standard conditions, but that spiro systems are accessible only when the formation of the fused system is blocked and require careful optimisation of reaction conditions. These systems display both weak antibacterial activity and proteasome inhibition.
spellingShingle Josa-Culleré, L
Towers, C
Willenbrock, F
Macaulay, V
Christensen, K
Moloney, M
Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems
title Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems
title_full Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems
title_fullStr Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems
title_full_unstemmed Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems
title_short Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems
title_sort synthesis and bioactivity of fused and spiro β lactone lactam systems
work_keys_str_mv AT josacullerel synthesisandbioactivityoffusedandspiroblactonelactamsystems
AT towersc synthesisandbioactivityoffusedandspiroblactonelactamsystems
AT willenbrockf synthesisandbioactivityoffusedandspiroblactonelactamsystems
AT macaulayv synthesisandbioactivityoffusedandspiroblactonelactamsystems
AT christensenk synthesisandbioactivityoffusedandspiroblactonelactamsystems
AT moloneym synthesisandbioactivityoffusedandspiroblactonelactamsystems